These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Relationships between serum adiponectin, apelin, leptin, resistin, visfatin levels and bone mineral density, and bone biochemical markers in post-menopausal Chinese women. Zhang H, Xie H, Zhao Q, Xie GQ, Wu XP, Liao EY, Luo XH. J Endocrinol Invest; 2010 Nov; 33(10):707-11. PubMed ID: 20208458 [Abstract] [Full Text] [Related]
5. The relationship of ghrelin and adiponectin with bone mineral density and bone turnover markers in elderly men. Gonnelli S, Caffarelli C, Del Santo K, Cadirni A, Guerriero C, Lucani B, Franci B, Nuti R. Calcif Tissue Int; 2008 Jul; 83(1):55-60. PubMed ID: 18563283 [Abstract] [Full Text] [Related]
6. Adipocytokines and breast cancer risk. Hou WK, Xu YX, Yu T, Zhang L, Zhang WW, Fu CL, Sun Y, Wu Q, Chen L. Chin Med J (Engl); 2007 Sep 20; 120(18):1592-6. PubMed ID: 17908478 [Abstract] [Full Text] [Related]
7. Blood leptin and adiponectin as possible mediators of the relation between fat mass and BMD in perimenopausal women. Kontogianni MD, Dafni UG, Routsias JG, Skopouli FN. J Bone Miner Res; 2004 Apr 20; 19(4):546-51. PubMed ID: 15005840 [Abstract] [Full Text] [Related]
8. Association between serum soluble membrane type matrix metalloproteinase-1 (MT1-MMP) levels and bone mineral density, and biochemical markers in postmenopausal women. Ren XH, Peng XD, Wu XP, Liao EY, Sun ZQ. Clin Chim Acta; 2008 Apr 20; 390(1-2):44-8. PubMed ID: 18230350 [Abstract] [Full Text] [Related]
11. Low circulating adiponectin and resistin, but not leptin, levels are associated with multiple myeloma risk: a case-control study. Dalamaga M, Karmaniolas K, Panagiotou A, Hsi A, Chamberland J, Dimas C, Lekka A, Mantzoros CS. Cancer Causes Control; 2009 Mar 20; 20(2):193-9. PubMed ID: 18814045 [Abstract] [Full Text] [Related]
12. The effect of infliximab on circulating levels of leptin, adiponectin and resistin in patients with inflammatory bowel disease. Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Kouroumalis EA. Eur J Gastroenterol Hepatol; 2007 Sep 20; 19(9):789-94. PubMed ID: 17700265 [Abstract] [Full Text] [Related]
13. Serum concentrations of leptin, adiponectin and resistin, and their relationship with cardiovascular disease in patients with end-stage renal disease. Díez JJ, Iglesias P, Fernández-Reyes MJ, Aguilera A, Bajo MA, Alvarez-Fidalgo P, Codoceo R, Selgas R. Clin Endocrinol (Oxf); 2005 Feb 20; 62(2):242-9. PubMed ID: 15670203 [Abstract] [Full Text] [Related]
19. Circulating visfatin in obese non-diabetic patients in relation to cardiovascular risk factors, insulin resistance, and adipocytokines: a contradictory piece of the puzzle. de Luis DA, Sagrado MG, Aller R, Conde R, Izaola O. Nutrition; 2010 Feb 20; 26(11-12):1130-3. PubMed ID: 19211226 [Abstract] [Full Text] [Related]